Among these KRAS is the most frequently mutated gene in CRC with a mutation frequency of 30%–40% (Siddiqi et al., 2009; Elsamany et al., 2014; Cárdenas-Ramos et al., 2017). Here, KRAS is linked to colorectal carcinoma.